Novadiscovery

Novadiscovery Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $5.57M
Latest Deal Amount
  • Investors
  • 3

Novadiscovery General Information

Description

Developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1 Place Verrazzano
  • 69009 Lyon
  • France
+33 09 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novadiscovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 09-Jan-2020 $5.57M 00.000 Completed Startup
2. Accelerator/Incubator 09-Feb-2016 Completed Startup
1. Grant 13-Jun-2015 Completed Startup

Novadiscovery Executive Team (4)

Name Title Board Seat Contact Info
François-Henri Boissel Co-Founder & Chief Executive Officer
Frederic Cogny Co-Founder & Chief Technology Officer
Jean-Pierre Boissel Co-Founder, Co-Chief Scientific Officer & Chairman of Scientific Advisory Board
David duVerle Ph.D Co-Chief Scientific Officer

Novadiscovery Board Members (1)

Name Representing Role Since
Jean-Pierre Boissel Novadiscovery Co-Founder, Co-Chief Scientific Officer & Chairman of Scientific Advisory Board 000 0000

Novadiscovery Investors (3)

To view Novadiscovery‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Debiopharm Innovation Fund Corporate Venture Capital Minority 000 0000 000000 0
BigBooster Accelerator/Incubator 000 0000 000000 0
H2020 Corporation 000 0000 000000 0

Ready to get started?

Request a free trial